CTKB
Cytek Biosciences Inc
5.40$
+0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +6.4% | +31.1% | +22.0% | -20.7% | +25.3% | +13.0% | +13.1% | -9.8% | +14.5% | +0.8% | +19.4% | -23.3% | +34.0% | -3.4% | +21.3% | -23.0% | +3.9% | +10.5% | +11.6% | -27.9% | +10.0% | +14.7% | +18.8% | -29.0% | +9.1% | – | |
| – | +13.0% | -12.8% | +17.8% | -12.4% | +9.0% | +22.8% | +16.5% | -2.4% | +4.8% | -12.7% | +39.3% | -15.4% | +34.1% | -3.3% | +21.0% | -13.3% | -3.0% | +6.2% | +5.9% | -10.6% | +2.0% | +13.8% | +18.2% | -21.8% | -13.5% | – | |
| – | -1.3% | +88.8% | +24.5% | -25.5% | +36.3% | +7.8% | +11.1% | -14.6% | +21.7% | +9.4% | +9.4% | -28.4% | +33.9% | -3.5% | +21.6% | -30.4% | +10.5% | +14.0% | +16.0% | -40.1% | +18.4% | +15.4% | +19.4% | -35.4% | +33.3% | – | |
| – | -3.3% | +15.8% | +29.9% | +16.2% | +21.6% | -1.9% | +16.4% | +13.4% | +5.1% | +2.5% | +12.7% | +2.3% | +21.7% | -8.0% | -2.7% | -9.9% | +2.1% | -1.2% | -1.6% | +0.0% | -9.2% | +1.5% | +0.1% | +7.2% | +1.4% | – | |
| – | -1.0% | -32.7% | +55.4% | +51.6% | +4.5% | +38.1% | +20.7% | +8.8% | +13.7% | -6.3% | +30.7% | +14.9% | -10.7% | -4.0% | +3.9% | +6.1% | +2.5% | -6.4% | -17.1% | +42.2% | +4.9% | +19.1% | +1.6% | +12.7% | -8.9% | – | |
| – | -6.6% | +4.9% | +30.0% | +15.4% | +19.3% | +15.4% | +21.4% | +1.0% | +12.9% | +0.2% | +14.9% | +13.3% | +12.3% | -9.9% | -1.2% | +1.7% | +0.6% | -2.1% | -7.8% | +14.6% | -1.8% | +6.5% | +4.7% | +3.2% | +0.1% | – | |
| – | – | – | +17.4% | -85.6% | +236.7% | -24.0% | -54.5% | -279.0% | – | – | -93.8% | -14,578.6% | – | – | – | – | – | – | – | -601.5% | – | – | – | – | – | – | |
| – | -98.8% | +100.0% | +16,400.0% | +13.6% | +15.5% | +1.8% | +11.6% | +19.9% | +9.7% | +0.3% | +5.9% | -2.0% | -39.2% | +45.5% | -33.8% | +11.9% | -69.6% | -11.2% | +483.2% | -58.1% | +42.3% | +19.3% | +46.8% | -63.9% | +7.3% | – | |
| – | – | +3,492.2% | +16.0% | -98.1% | +2,049.3% | -36.5% | -78.6% | -843.9% | – | – | +122.4% | -319.7% | – | – | – | -318.8% | – | – | +6,475.2% | -209.1% | – | – | – | – | – | – | |
| – | -4,548.9% | – | +573.1% | -97.9% | +1,094.0% | +9.7% | +145.6% | -171.2% | – | – | +76.8% | -663.9% | – | – | -161.3% | – | – | -124.1% | – | -80.0% | -976.5% | – | – | -96.3% | -65.5% | – | |
| – | – | -19.4% | -14.4% | -98.2% | +2,517.6% | -46.8% | -183.9% | – | – | – | +111.8% | -292.9% | – | – | – | -212.1% | – | – | +924.8% | -218.2% | – | – | – | – | – | – | |
| – | – | +1,899.4% | +19.9% | -91.8% | +462.1% | -30.7% | -40.1% | -176.7% | – | +2,819.6% | +103.8% | -210.5% | – | – | – | -187.9% | – | – | -179.5% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.